Đang chuẩn bị liên kết để tải về tài liệu:
Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Renal cell carcinoma (RCC) is a malignant disease that demonstrates resistance to standard chemotherapeutic agents. Yet Active immunization using genetically modified dendritic cells holds promise for the adjuvant treatment of malignancies to eradicate or control residual disease. |

TÀI LIỆU LIÊN QUAN

All that glitters is not gold in evaluating clinical research (Second edition): Part 1

OPPORTUNITIES TO ADDRESS CLINICAL RESEARCH WORKFORCE DIVERSITY NEEDS FOR 2O1O

Induced pluripotent stem cells are Japanese brand sources for therapeutic cells to pretrial clinical research

Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation

Ebook Neurological rehabilitation - Spasticity and contractures in clinical practice and research: Part 1

Ebook Neurological rehabilitation - Spasticity and contractures in clinical practice and research: Part 2

Exploring Challenges, Progress, and New Models for ENGAGING THE PUBLIC in the CLINICAL RESEARCH ENTERPRISE Clinical Research Roundtable Workshop Summary

Ebook Designing clinical research (3/E): Part 1

Barriers to research utilization and research use among registered nurses working in the care of older people: Does the BARRIERS Scale discriminate between research users and non-research users on perceptions of barriers?

Research on the clinical features of children with attention deficit hyperactivity disorder see the doctors in the first time at Danang Psychiatric Hospital
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.